Pentadecapeptide (BPC Variant) Protocol
Pentadecapeptide refers to the class of 15-amino acid Body Protection Compound peptides derived from human gastric juice, primarily BPC-157 and its variant formulations. The term encompasses different salt forms (acetate for injection, arginine salt for oral stability), modified sequences, and combination approaches. These pentadecapeptides exhibit remarkable tissue-protective properties including wound healing acceleration, anti-inflammatory effects, gastrointestinal protection, neuroprotection, and pro-angiogenic activity through VEGF upregulation, NO system modulation, and FAK-paxillin pathway activation. This protocol covers both injectable (acetate) and oral (arginine salt) administration routes, comparative dosing, form selection guidance, and stacking for comprehensive tissue repair research.
Protocol Overview
- Compound
- Pentadecapeptide (BPC-157 variants)
- Category
- Tissue Repair / Gastric Protection
- Mechanism
- Multi-pathway tissue repair: VEGF upregulation, NO system modulation, FAK-paxillin pathway, anti-inflammatory cytokine modulation, gut-brain axis support
- Molecular Weight
- ~1,419 g/mol (BPC-157 free base)
- Forms
- Acetate salt (SubQ) | Arginine salt (oral, acid-stable)
- Route
- Subcutaneous and/or Oral
- Frequency
- 1-2x daily
- Cycle Length
- 4-8 weeks on, 2-4 weeks off
Dosing Protocol
| Protocol | Dose | Form | Frequency | Duration |
|---|---|---|---|---|
| SubQ Standard | 250 mcg | Acetate | 1-2x daily | 4-8 weeks |
| Oral Standard | 250-500 mcg | Arginine salt | 2x daily (empty stomach) | 4-8 weeks |
| Combined Protocol | 250 mcg SubQ + 250 mcg oral | Acetate + Arginine | 1x each daily | 4-8 weeks |
| High-Dose Repair | 500 mcg | Acetate | 2x daily near injury | 4-6 weeks |
Key principle: Choose form based on target: acetate (SubQ) for musculoskeletal injuries, systemic repair, and localized healing; arginine salt (oral) for GI conditions, gut barrier repair, and gut-brain axis modulation. The combined protocol provides maximal coverage across both systemic and GI pathways.
Form Selection Guide
Acetate Salt (Injectable)
- Best for: Musculoskeletal injuries, tendon/ligament repair
- Route: Subcutaneous, near injury site
- Reconstitution: 2mL BAC water per 5mg vial
- Advantage: Higher bioavailability, localized effect
- 250mcg dose: 10 units from 2.5mg/mL solution
Arginine Salt (Oral)
- Best for: GI repair, IBS, leaky gut, gut-brain axis
- Route: Oral, on empty stomach
- Form: Capsules or reconstituted in water
- Advantage: Survives stomach acid, GI tract exposure
- Note: Higher doses needed for systemic effects
Expected Timeline
Side Effects & Monitoring
Common Side Effects
- Injection site redness (SubQ, mild and transient)
- Mild nausea with oral form (uncommon)
- Slight drowsiness (rare)
BPC pentadecapeptides have shown no toxicity in extensive preclinical research. They are derived from naturally occurring gastric juice proteins with an exceptional safety profile.
Precautions
- Theoretical concern with active cancer (pro-angiogenic)
- Limited formal human clinical trial data
- Monitor for changes in blood pressure (NO modulation)
- Not recommended during pregnancy
Stacking Recommendations
Compatible Compounds
- TB-500: Complementary tissue repair pathway (thymosin)
- GHK-Cu: Collagen synthesis and wound healing
- AOD-9604: Fat loss without compromising healing
- Thymosin Alpha-1: Immune support alongside repair
- L-Glutamine: Gut barrier substrate support
Popular Stacks
- Injury Recovery: BPC 250mcg SubQ + TB-500 2mg 2x/wk
- Gut Healing: BPC oral 500mcg 2x/day + L-Glutamine 5g
- Full Repair: BPC SubQ + oral + GHK-Cu 200mcg
Blood Work Recommendations
| Panel | Markers | Timing |
|---|---|---|
| Inflammation | hs-CRP, ESR, IL-6 | Baseline, Week 4, Week 8 |
| GI Health | Zonulin, calprotectin (stool) | Baseline, Week 8 |
| Liver Function | ALT, AST, GGT | Baseline, Week 8 |
| General | CBC, CMP | Baseline, Week 8 |
Related Tools & Resources
